Security Overview
Plain-language explanation of the CRIS security model.
TRUST CENTRE
Healthcare organisations should not have to rely on website claims when evaluating software that may handle sensitive operational, financial or patient-related information.
The CRIS Trust Centre provides a structured place for security, privacy, technology, procurement, compliance and risk teams to review how CRIS approaches protection, access, deployment and accountability.
Use it to understand the control model, review available documentation, request security information and prepare for technical or procurement due diligence.
Know where the boundaries are before you trust the platform.
BUYER QUESTIONS
Security reviews rarely begin with:
“Does the software have a login?”
They begin with harder questions.
The CRIS Trust Centre is designed to make those questions easier to investigate.
Built for the questions buyers ask before approval.
Security reviews rarely begin with:
“Does the software have a login?”
They begin with harder questions.
Where will our information be stored?
How are customers separated?
Who can access patient-related information?
Can access be limited by organisation or facility?
Is patient identity exposed unnecessarily?
How are privileged users controlled?
What happens to uploaded documents?
Can important activity be audited?
How are vulnerabilities managed?
How are backups tested?
What happens during an incident?
How is information deleted?
What access does the provider retain?
Which controls are platform responsibilities and which remain ours?
What evidence exists?
The CRIS Trust Centre is designed to make those questions easier to investigate.
ASSURANCE MODEL
A security statement tells you what a vendor says. A control description tells you what the product is designed to do. Evidence helps you evaluate whether that control has actually been implemented and tested in the relevant environment.
That distinction is central to the CRIS approach to production readiness.
START HERE
Security architecture
Understand how CRIS approaches tenant separation, user access, privileged access, patient identity, files, auditability and sensitive actions.
Privacy architecture
Understand how CRIS seeks to minimise unnecessary identity exposure, control access to patient information and support governed retention and deletion.
Deployment controls
Review the considerations that apply when CRIS moves from demonstration or evaluation into a customer-approved production environment.
Production readiness
Understand which controls may require implementation evidence, testing and approval before sensitive production information is introduced.
Procurement & due diligence
Request questionnaires, architecture information, policy material and other available evidence required by your procurement, risk or technology review.
Policies & governance
Review the public policies and governance information currently available for CRIS.
SECURITY ARCHITECTURE
CRIS is designed around multiple security boundaries rather than relying on a single login screen.
The purpose is straightforward:
A person should be able to access what their work requires without automatically gaining access to everything else.
Explore Security & TrustSecurity architecture
Know where the boundaries are before you trust the platform.
CRIS is designed around multiple security boundaries rather than relying on a single login screen.
Those boundaries can include:
Customer or tenant.
Organisation.
Facility.
Role.
User.
Module.
Record.
Patient identity.
Sensitive action.
Administrative privilege.
Private file.
The purpose is straightforward:
A person should be able to access what their work requires without automatically gaining access to everything else.
Areas covered by the CRIS security model
Tenant separation
Controls intended to prevent one customer environment from accessing another.
Facility and organisational scope
Controls for limiting access within a multi-facility or multi-organisation environment.
Role-based access
Permissions aligned with authorised user responsibilities.
Patient identity controls
Patient Key, masked identity and controlled identity reveal where configured.
Privileged access
Additional governance around administrative and elevated access.
Private files
Controlled access to uploaded evidence and supporting documentation.
Audit
Evidence of important system, administrative and sensitive activity.
Lineage
Ability to understand how important business results relate to underlying source evidence.
Retention and deletion
Support for approved information lifecycle requirements.
Privacy architecture
Use the information you need without exposing more than the work requires.
A revenue-cycle system may need to understand that multiple records belong to the same patient.
That does not mean every user, dashboard or analytical process needs to display that patient's full identity.
CRIS is designed around the principle of minimising unnecessary exposure.
Where appropriate, the architecture can distinguish between:
The revenue-cycle fact
and
The identity behind the fact.
This enables financial and operational analysis to remain useful while limiting direct patient identity to situations where authorised work genuinely requires it.
Privacy controls may include
Patient Key.
Masked identity.
Controlled reveal.
Patient Identity Vault where deployed.
Role and scope restrictions.
Private supporting files.
Audit evidence for sensitive access.
Governed retention.
Controlled deletion.
Customer-defined access responsibility.
These mechanisms support a privacy architecture.
They do not remove the customer's responsibility to define appropriate use, workforce access, retention and legal obligations.
PRIVACY ARCHITECTURE
A revenue-cycle system may need to understand that multiple records belong to the same patient.
That does not mean every user, dashboard or analytical process needs to display that patient's full identity.
CRIS is designed around the principle of minimising unnecessary exposure.
DEPLOYMENT CONTROLS
The security of CRIS cannot be evaluated only from the application screen.
A platform can be well designed and still be deployed badly.
Production security therefore also depends on the environment in which CRIS is operated.
PRODUCTION READINESS
Before sensitive production use, the relevant customer and CRIS teams should be able to determine whether required safeguards have been:
| Control area | Evidence that may be requested |
|---|---|
| Security architecture | Approved architecture and access-control design |
| Authentication | Authentication configuration and test evidence |
| MFA | Implementation and verification evidence |
| Tenant isolation | Isolation testing |
| Facility isolation | Facility-scope testing where applicable |
| Privileged access | Administrative access review |
| Patient identity | Masking, Patient Key and reveal-control test evidence |
| Encryption | Encryption and key-management verification |
| Audit controls | Logging and sensitive-action traceability evidence |
| Vulnerability management | Current assessment and remediation status |
| Backup | Backup integrity evidence |
| Recovery | Restore or recovery test evidence |
| Incident response | Approved response process and testing evidence |
| Retention | Approved retention configuration |
| Deletion | Deletion or purge-control evidence where applicable |
| Support access | Support and platform administration access standard |
| Third parties | Relevant vendor or subprocessor governance information |
Deployment matters.
The security of CRIS cannot be evaluated only from the application screen.
A platform can be well designed and still be deployed badly.
Production security therefore also depends on the environment in which CRIS is operated.
A deployment review may need to consider:
Hosting architecture.
Network configuration.
Encryption.
Authentication.
Multi-factor authentication.
Administrative access.
Key management.
Backup arrangements.
Recovery testing.
Logging.
Monitoring.
Vulnerability management.
Support access.
Retention configuration.
Incident response.
Third-party services.
Customer responsibilities.
The exact requirements depend on the approved deployment.
Evaluation is not production.
A demonstration environment may be suitable for:
Product evaluation.
Workflow review.
Interface testing.
Synthetic data.
Training.
Commercial discussion.
Architecture review.
It should not automatically be treated as approved for sensitive production information.
Moving to production requires a separate decision based on the safeguards implemented for the actual customer environment.
Production readiness
A control is not complete simply because a setting exists.
Before sensitive production use, the relevant customer and CRIS teams should be able to determine whether required safeguards have been:
Configured.
Tested.
Reviewed.
Approved.
Evidenced.
The evidence required will depend on the deployment and the customer's requirements.
Examples of production security evidence
Control area
Evidence that may be requested
Security architecture
Approved architecture and access-control design
Authentication
Authentication configuration and test evidence
MFA
Implementation and verification evidence
Tenant isolation
Isolation testing
Facility isolation
Facility-scope testing where applicable
Privileged access
Administrative access review
Patient identity
Masking, Patient Key and reveal-control test evidence
Encryption
Encryption and key-management verification
Audit controls
Logging and sensitive-action traceability evidence
Vulnerability management
Current assessment and remediation status
Backup
Backup integrity evidence
Recovery
Restore or recovery test evidence
Incident response
Approved response process and testing evidence
Retention
Approved retention configuration
Deletion
Deletion or purge-control evidence where applicable
Support access
Support and platform administration access standard
Third parties
Relevant vendor or subprocessor governance information
SECURITY DOCUMENT LIBRARY
The Trust Centre should progressively become the single location for CRIS security and due-diligence material.
Plain-language explanation of the CRIS security model.
Higher-level description of security boundaries, access control, identity handling and platform safeguards.
Explanation of patient identity minimisation, Patient Key, masking, controlled reveal and related privacy controls.
Description of roles, permissions, scope and privileged access.
Description of the approach used to keep customer environments separated.
Description of Patient Key, masking, controlled reveal and Identity Vault architecture where applicable.
Description of audit evidence, sensitive actions and lineage.
Description of how governed files are intended to remain behind authorised application access.
Explanation of how customer-approved retention and deletion requirements can be implemented.
How identified vulnerabilities are assessed, prioritised and addressed.
The framework for identifying, assessing, responding to and learning from security incidents.
The approach to backup, restoration and recovery assurance.
The controls that should be reviewed before approving a CRIS production environment.
How elevated platform and administrative access is governed.
How authorised support access should be controlled and reviewed.
Security document library
Find the document you need without searching through marketing pages.
The Trust Centre should progressively become the single location for CRIS security and due-diligence material.
Documents should carry clear availability labels so buyers know what can be reviewed publicly and what requires a formal request.
PUBLIC
Available without additional approval.
AVAILABLE ON REQUEST
Provided to legitimate customers, prospects or authorised reviewers following an appropriate request.
CONTROLLED ACCESS
May require confidentiality terms, customer verification or another controlled review process.
DEPLOYMENT SPECIFIC
Created or completed for the relevant production environment rather than published as a generic document.
Security & privacy documents
The library may include:
Security Overview
Plain-language explanation of the CRIS security model.
Availability: Public
Security Architecture Overview
Higher-level description of security boundaries, access control, identity handling and platform safeguards.
Availability: Available on request
Privacy Architecture Overview
Explanation of patient identity minimisation, Patient Key, masking, controlled reveal and related privacy controls.
Availability: Public / Available on request as appropriate
Access Control Model
Description of roles, permissions, scope and privileged access.
Availability: Available on request
Tenant Isolation Overview
Description of the approach used to keep customer environments separated.
Availability: Available on request
Patient Identity Control Overview
Description of Patient Key, masking, controlled reveal and Identity Vault architecture where applicable.
Availability: Available on request
Audit & Traceability Overview
Description of audit evidence, sensitive actions and lineage.
Availability: Available on request
Private File Handling Overview
Description of how governed files are intended to remain behind authorised application access.
Availability: Available on request
Retention & Deletion Approach
Explanation of how customer-approved retention and deletion requirements can be implemented.
Availability: Available on request
Operational security documents
Vulnerability Management Standard
How identified vulnerabilities are assessed, prioritised and addressed.
Availability: Controlled access
Incident Response Standard
The framework for identifying, assessing, responding to and learning from security incidents.
Availability: Controlled access
Backup & Recovery Standard
The approach to backup, restoration and recovery assurance.
Availability: Controlled access
Secure Deployment Checklist
The controls that should be reviewed before approving a CRIS production environment.
Availability: Available on request
Privileged Access Standard
How elevated platform and administrative access is governed.
Availability: Controlled access
Support Access Standard
How authorised support access should be controlled and reviewed.
Availability: Controlled access
Public policies
Some trust information should not require a due-diligence request.
Public website policies should remain accessible directly from the Trust Centre.
Privacy Policy
Explains how the CRIS public website handles information submitted through the website.
Terms of Use
Explains the terms governing use of the public CRIS website.
Security & Trust
Explains the CRIS control philosophy and security architecture in accessible language.
PUBLIC POLICIES
SECURITY QUESTIONNAIRES
Healthcare buyers often have their own security, IT, risk or privacy questionnaires.
CRIS should not force procurement teams to translate their review into a vendor-specific template.
If your organisation already uses a questionnaire, send it to the CRIS team for review.
Security questionnaires
Send us the questions your organisation already uses.
Healthcare buyers often have their own security, IT, risk or privacy questionnaires.
CRIS should not force procurement teams to translate their review into a vendor-specific template.
If your organisation already uses a questionnaire, send it to the CRIS team for review.
Common subjects may include:
Hosting.
Encryption.
Authentication.
MFA.
Password requirements.
Tenant isolation.
Access control.
Patient identity.
Logging.
Audit.
Vulnerability management.
Penetration testing.
Backup.
Disaster recovery.
Business continuity.
Incident management.
Retention.
Deletion.
Support access.
Subprocessors.
Data location.
Secure development.
Change management.
Privacy.
Contractual security requirements.
What happens after you submit a questionnaire?
1. We review the request.
The CRIS team identifies the information required and the appropriate reviewers.
2. Public information is referenced first.
Where the answer already exists in the Trust Centre, we point you to the relevant material.
3. Controlled information is handled separately.
Sensitive architecture or security evidence may require appropriate confidentiality and access controls.
4. Deployment-specific questions are identified.
Some questions cannot be answered meaningfully until the proposed customer environment is understood.
5. Open matters are discussed directly.
Where a question depends on configuration, responsibility or customer requirements, the answer should be clarified rather than guessed.
Due diligence should separate platform capability from deployment responsibility.
Some questions have a CRIS-wide answer.
Others depend on the customer.
For example:
Does CRIS support role-based access?
That is primarily a platform question.
Which employees should receive which roles?
That is primarily a customer governance question.
Can CRIS support controlled patient identity reveal?
That is a platform question.
Which employees are authorised to reveal identity?
That is a customer policy and deployment question.
Can CRIS support retention controls?
That is a platform question.
How long must this customer's information be retained?
That depends on the customer, applicable obligations and approved policy.
A good security review keeps those responsibilities clear.
Request security information
Tell us what your review requires.
Organisation *
Full name *
Work email *
Role / title *
Country
Review type *
Options:
Security review
Privacy review
Procurement due diligence
IT architecture review
Risk assessment
Compliance review
Customer onboarding
Other
What do you need?
Security questionnaire
Architecture documentation
Privacy documentation
Access-control information
Patient identity controls
Hosting information
Vulnerability-management information
Backup and recovery information
Incident-response information
Retention and deletion information
Third-party / subprocessor information
Production-readiness information
Other
Upload questionnaire
Upload your organisation's existing security or procurement questionnaire if applicable.
Do not upload patient information, claim data, medical records or other production healthcare information through this form.
Additional context
Tell us which questions you are trying to resolve so the appropriate information can be provided.
SHARED RESPONSIBILITY
The final responsibility model should be documented for the actual deployment.
Shared responsibility
Security works when platform controls and customer governance meet.
CRIS may be responsible for
Platform security controls.
Application-level tenant separation.
Platform access-control capabilities.
Patient identity-control mechanisms.
Audit and lineage capabilities.
Private-file mechanisms.
Platform maintenance.
Security controls within the contracted CRIS service boundary.
The customer may be responsible for
Approving users.
Assigning appropriate roles.
Removing access when employment or responsibility changes.
Defining legitimate use.
Approving patient identity access.
Controlling local endpoints.
Managing local networks.
Determining retention requirements.
Approving imported information.
Governing exports.
Managing downstream use.
Meeting organisation-specific legal, regulatory and contractual requirements.
The final responsibility model should be documented for the actual deployment.
Compliance questions deserve precise answers.
CRIS should not replace evidence with badges.
The Trust Centre should not use unsupported statements such as:
“Completely secure.”
“100% protected.”
“HIPAA certified.”
“Zero risk.”
“Guaranteed compliance.”
Those phrases reduce complicated security and compliance responsibilities to marketing claims.
CRIS should instead explain:
What controls exist.
Where they apply.
What remains customer responsibility.
What evidence is available.
What still requires production implementation or testing.
That gives a buyer something more useful than a badge.
HIPAA and healthcare security
HIPAA applicability and compliance depend on more than the presence of software features.
Relevant considerations can include:
The entities involved.
The information being handled.
The contractual relationship.
The production environment.
Administrative safeguards.
Technical safeguards.
Physical safeguards.
Policies.
Workforce practices.
Third parties.
Customer responsibilities.
Actual implementation.
CRIS therefore treats healthcare security readiness as a control-and-evidence process.
Where HIPAA or another healthcare requirement applies, the actual deployment should be evaluated with the appropriate security, privacy, compliance and legal stakeholders.
COMPLIANCE & HEALTHCARE SECURITY
CRIS should not replace evidence with badges.
HIPAA applicability and compliance depend on more than the presence of software features.
CRIS therefore treats healthcare security readiness as a control-and-evidence process.
CURRENT TRUST CENTRE STATUS
The Trust Centre should publish material when it is sufficiently complete, approved and appropriate for customer use.
Material should not be published merely to make the library appear larger.
During the initial CRIS release, some detailed security documentation may therefore remain available only through direct due diligence.
Current Trust Centre status
The evidence library will grow with the platform.
The Trust Centre should publish material when it is sufficiently complete, approved and appropriate for customer use.
Material should not be published merely to make the library appear larger.
During the initial CRIS release, some detailed security documentation may therefore remain available only through direct due diligence.
Where a dedicated Trust Centre document is not yet published, users should be directed to the relevant Security & Trust information or invited to request the material.
Before sharing detailed evidence
Some security information should not be published openly.
Depending on the request, CRIS may need to confirm:
Your organisation.
Your role.
The purpose of the review.
Whether you are evaluating or already using CRIS.
The proposed deployment.
Which documents are required.
Whether confidentiality terms apply.
This is not intended to make due diligence difficult.
It is intended to avoid turning sensitive security documentation into unrestricted public material.
BUYER FAQ
CRIS should not describe itself as “HIPAA certified.”
HIPAA readiness depends on the relevant organisation, deployment, safeguards, responsibilities and operating environment. CRIS instead provides controls intended to support appropriate healthcare security and a process for reviewing implementation evidence.
CRIS is designed for controlled separation between customer environments. The precise architecture and relevant testing evidence can be reviewed through the security due-diligence process.
The CRIS access model is designed to support scoped access, including organisational and facility boundaries where required by the deployment.
No. CRIS is designed to support identity minimisation, masking and controlled patient identity access where appropriate.
Higher-level architecture information can be made available as part of legitimate technical and security due diligence. More sensitive architectural material may require controlled access.
Relevant security-assurance information can be considered during controlled due diligence as it becomes available and appropriate for disclosure.
Where third parties or subprocessors are relevant to a production service, the applicable information should be made available through the appropriate customer documentation and due-diligence process.
Appropriate security information should be available during legitimate procurement and technical evaluation. Some material may require confidentiality terms before release.
No.
Public documentation can explain controls and architecture.
Production approval requires evaluation of the actual deployment and whatever implementation and test evidence the customer requires.
Questions buyers frequently ask
Is CRIS HIPAA certified?
CRIS should not describe itself as “HIPAA certified.”
HIPAA readiness depends on the relevant organisation, deployment, safeguards, responsibilities and operating environment. CRIS instead provides controls intended to support appropriate healthcare security and a process for reviewing implementation evidence.
Does CRIS support tenant isolation?
CRIS is designed for controlled separation between customer environments. The precise architecture and relevant testing evidence can be reviewed through the security due-diligence process.
Can CRIS restrict users by facility?
The CRIS access model is designed to support scoped access, including organisational and facility boundaries where required by the deployment.
Does every user see patient names?
No. CRIS is designed to support identity minimisation, masking and controlled patient identity access where appropriate.
Can we review the CRIS architecture?
Higher-level architecture information can be made available as part of legitimate technical and security due diligence. More sensitive architectural material may require controlled access.
Can we send our own security questionnaire?
Yes.
Do you provide penetration-testing or vulnerability information?
Relevant security-assurance information can be considered during controlled due diligence as it becomes available and appropriate for disclosure.
Does CRIS publish a list of subprocessors?
Where third parties or subprocessors are relevant to a production service, the applicable information should be made available through the appropriate customer documentation and due-diligence process.
Can we obtain security documentation before signing?
Appropriate security information should be available during legitimate procurement and technical evaluation. Some material may require confidentiality terms before release.
Is website security evidence the same as production approval?
No.
Public documentation can explain controls and architecture.
Production approval requires evaluation of the actual deployment and whatever implementation and test evidence the customer requires.
What the Trust Centre should eventually contain
As CRIS matures, /trust should become a governed document portal rather than a long static page.
The future Trust Centre can include:
Searchable security documentation.
Document version numbers.
Publication dates.
Document owners.
Review dates.
Public versus controlled-access classification.
Secure document requests.
Buyer questionnaire workflow.
NDA-controlled downloads.
Subprocessor register.
Security advisories.
Service status.
Incident communication information.
Production-readiness checklists.
Compliance mappings where appropriate.
Assessment reports where approved for disclosure.
Release security information.
Historical document versions where required.
That allows CRIS to move from merely explaining trust to providing a structured security assurance programme.
The Trust Centre should answer one question clearly.
“What can we review before we trust CRIS with our environment?”
The answer should not be:
“Trust us.”
It should be:
Review the architecture.
Understand the boundaries.
Inspect the policies.
Ask the hard questions.
Establish the responsibilities.
Review the available evidence.
Test the actual deployment.
Approve sensitive production use only when the required controls are ready.
That is what the CRIS Trust Centre is for.
FINAL CTA
Whether you are evaluating CRIS for one facility or an organisation-wide deployment, our team can help your procurement, security, privacy, technology and risk reviewers understand the relevant controls and identify the evidence required for your environment.